Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5885755 | Journal of Critical Care | 2012 | 8 Pages |
Abstract
Our study suggests that nicardipine is a more effective antihypertensive agent than labetalol in an unselected group of patients who develop hypertension in the intensive care unit setting. A major advantage of nicardipine compared with labetalol was fewer adverse effects. Nicardipine was associated with less hypotension and bradycardia or atrioventricular block, resulting in a lower rate of drug discontinuation compared with labetalol.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Mark A. PharmD, Daniel E. PharmD,